News
MBIO
0.5872
-3.02%
-0.0183
Weekly Report: what happened at MBIO last week (0511-0515)?
Weekly Report · 5h ago
Weekly Report: what happened at MBIO last week (0504-0508)?
Weekly Report · 05/11 09:32
Mustang Bio Q1 net loss widens to $955,000; operating loss increases to $1.06 million
PUBT · 05/05 20:05
Weekly Report: what happened at MBIO last week (0427-0501)?
Weekly Report · 05/04 09:31
Weekly Report: what happened at MBIO last week (0420-0424)?
Weekly Report · 04/27 09:32
Weekly Report: what happened at MBIO last week (0413-0417)?
Weekly Report · 04/20 09:31
Mustang Bio gets Nasdaq notice after shares trade below $1 for 30 days
PUBT · 04/17 20:02
Weekly Report: what happened at MBIO last week (0406-0410)?
Weekly Report · 04/13 09:32
Weekly Report: what happened at MBIO last week (0330-0403)?
Weekly Report · 04/06 09:32
Weekly Report: what happened at MBIO last week (0323-0327)?
Weekly Report · 03/30 09:32
Weekly Report: what happened at MBIO last week (0316-0320)?
Weekly Report · 03/23 09:31
Mustang Bio FY 2025 net loss narrows 88% to USD 1.92 million on R&D expense down 118% to USD -1.52 million
Reuters · 03/19 20:09
Weekly Report: what happened at MBIO last week (0309-0313)?
Weekly Report · 03/16 09:30
Weekly Report: what happened at MBIO last week (0302-0306)?
Weekly Report · 03/09 09:31
Weekly Report: what happened at MBIO last week (0223-0227)?
Weekly Report · 03/02 09:31
Weekly Report: what happened at MBIO last week (0216-0220)?
Weekly Report · 02/23 09:30
Weekly Report: what happened at MBIO last week (0209-0213)?
Weekly Report · 02/16 09:30
Weekly Report: what happened at MBIO last week (0202-0206)?
Weekly Report · 02/09 09:31
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 02/06 12:05
Weekly Report: what happened at MBIO last week (0126-0130)?
Weekly Report · 02/02 09:31
More
Webull provides a variety of real-time MBIO stock news. You can receive the latest news about Mustang Bio through multiple platforms. This information may help you make smarter investment decisions.
About MBIO
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on translating medical breakthroughs into potential cures for cancers and autoimmune diseases. The Company has partnered with medical institutions to advance the development of chimeric antigen receptor modified T cell (CAR T) therapies. Its pipeline is focused in two core areas: CAR T therapies for autoimmune diseases and hematologic malignancies and CAR T therapies for solid tumors. It is developing a CAR T therapy for hematologic malignancies and autoimmune diseases in partnership with Fred Hutchinson Cancer Center targeting CD20 and for solid tumors in partnership with City of Hope National Medical Center targeting IL13Ra2. It has also partnered with Nationwide Children’s Hospital for a herpes simplex virus type 1 oncolytic virus to enhance the activity of MB-101 for the treatment of patients with high-grade malignant brain tumors.